drugset / Trial / NCT00947960

Triheptanoin Treatment Trial for Patients With Adult Polyglucosan Body Disease

NCT00947960

RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of the study is to determine if triheptanoin is an effective treatment for the symptoms of Adult Polyglucosan Body Disease.

Timeline

Start
2009-06
Primary completion
2015-07
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Triheptanoin Other / unclassified 1 g/kg Oral
Subject Triheptanoin Other / unclassified 2 g/kg Oral